{"protocolSection": {"identificationModule": {"nctId": "NCT03158311", "orgStudyIdInfo": {"id": "CQVM149B2306"}, "secondaryIdInfos": [{"id": "2017-000136-34", "type": "EUDRACT_NUMBER"}], "organization": {"fullName": "Novartis", "class": "INDUSTRY"}, "briefTitle": "Study to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + Tiotropium", "officialTitle": "A Multicenter, Partially-Blinded, Randomized, 24-Week, Parallel-Group, Non-Inferiority, Open-Label Active Controlled Study to Compare the Efficacy and Safety of QVM149 With a Free Triple Combination of Salmeterol/Fluticasone + Tiotropium in Patients With Uncontrolled Asthma", "acronym": "ARGON"}, "statusModule": {"statusVerifiedDate": "2021-10", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2018-02-05", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2019-07-12", "type": "ACTUAL"}, "completionDateStruct": {"date": "2019-07-19", "type": "ACTUAL"}, "studyFirstSubmitDate": "2017-05-16", "studyFirstSubmitQcDate": "2017-05-16", "studyFirstPostDateStruct": {"date": "2017-05-18", "type": "ACTUAL"}, "resultsFirstSubmitDate": "2020-07-15", "resultsFirstSubmitQcDate": "2020-09-21", "resultsFirstPostDateStruct": {"date": "2020-10-14", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2021-10-07", "lastUpdatePostDateStruct": {"date": "2021-10-08", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Novartis Pharmaceuticals", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false, "isFdaRegulatedDrug": false, "isFdaRegulatedDevice": false}, "descriptionModule": {"briefSummary": "The purpose of this trial was to demonstrate that the efficacy of two treatment arms of the fixed-dose combination product QVM149 was non-inferior to the efficacy of the free combination arm of salmeterol/ fluticasone+ tiotropium in uncontrolled moderate to severe asthmatic patients.\n\nThe planned duration of treatment in this study was 24 weeks, followed up by a 7-day follow-up period.", "detailedDescription": "This study used a randomized, partially-blinded, 24-week, parallel-group, non-inferiority, open-label active controlled design. The study was partially open-label. Investigators and patients had knowledge of treatment allocation between QVM149 and/or comparator, however the QVM149 strength allocation was masked. The global sponsor team responsible for data review and analysis was blinded to all treatment allocations The study consisted of a screening period of up to 1-week, run-in period of 2-weeks, randomized treatment period of 24-weeks, and a follow-up period of 1-week.\n\nAt the screening visit, informed consent was obtained, and current and prohibited medications were reviewed. Rescue medication was provided to all patients who met the eligibility criteria and was to be used on an \"as needed\" basis throughout the study.\n\nAt the run-in visit, inclusion and exclusion criteria were reviewed and the patients were supplied with open-label long acting \u03b22-adrenergic agonist/inhaled corticosteroids (LABA/ICS) salmeterol/fluticasone 50/250 \u03bcg b.i.d or 50/500 \u03bcg b.i.d to match their ICS background medication dose to be stopped at randomization visit.\n\nAll patients who met the eligibility criteria were randomized to 1 of 3 treatment arms with a randomization ratio of 1:1:1. The patients were stratified at randomization according to the ICS dose component of background ICS/LABA (medium or high dose) and region.\n\nTreatment period visits were scheduled every 8 weeks. The study used two doses of QVM149 (high dose \\[150/50/160 \u03bcg\\] and a medium dose \\[150/50/80 \u03bcg\\] o.d. delivered via Concept1 inhaler) and a comparator treatment (salmeterol/fluticasone 50/500 \u03bcg b.i.d. delivered via Accuhaler\u00ae plus tiotropium 5 \u03bcg o.d delivered via Respimat\u00ae).\n\nAll randomized patients were contacted (by telephone) 7 days following the last dose of study medication or last visit, whichever was later, for Safety Follow-up visit."}, "conditionsModule": {"conditions": ["Asthma"], "keywords": ["QVM149", "Asthma", "Moderate Asthma", "Severe Asthma", "ICS/LABA/LAMA", "ICS/LABA", "LAMA", "Adult"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "interventionModelDescription": "Parallel Assignment", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "SINGLE", "maskingDescription": "The free triple combination of salmeterol/fluticasone + tiotropium was open label, for which investigators and patients had full knowledge that the patient had been assigned free triple combination comparator treatment. Within the two QVM149 treatment arms patients, investigator staff, and persons performing the assessments, remained blind to the identity of the actual QVM149 treatment dose but had full knowledge that the patient had been assigned QVM149 as study treatment. The data analysts and sponsor team were blinded to Case Report Forms that reveal the treatment arm. Randomization data and treatment codes were kept strictly confidential until the time of unblinding, and was not accessible by anyone else involved in the study.", "whoMasked": ["OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 1426, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "QVM149 150/50/80 \u03bcg", "type": "EXPERIMENTAL", "description": "QVM149 150/50/80 \u03bcg o.d. delivered via Concept1", "interventionNames": ["Drug: QVM149"]}, {"label": "QVM149 150/50/160 \u03bcg", "type": "EXPERIMENTAL", "description": "QVM149 150/50/160 \u03bcg o.d. delivered via Concept1", "interventionNames": ["Drug: QVM149"]}, {"label": "Salmeterol/fluticasone 50/500 \u03bcg plus tiotropium 5 \u03bcg", "type": "ACTIVE_COMPARATOR", "description": "Salmeterol/fluticasone 50/500 \u03bcg b.i.d. delivered via Accuhaler\u00ae plus tiotropium 5 \u03bcg o.d. delivered via Respimat\u00ae", "interventionNames": ["Drug: Salmeterol/fluticasone plus tiotropium"]}], "interventions": [{"type": "DRUG", "name": "QVM149", "description": "Indacaterol acetate / glycopyrronium bromide / mometasone furoate", "armGroupLabels": ["QVM149 150/50/160 \u03bcg", "QVM149 150/50/80 \u03bcg"]}, {"type": "DRUG", "name": "Salmeterol/fluticasone plus tiotropium", "description": "Free triple arm of salmeterol / fluticasone plus tiotropium", "armGroupLabels": ["Salmeterol/fluticasone 50/500 \u03bcg plus tiotropium 5 \u03bcg"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Change From Baseline in Asthma Quality of Life Questionnaire (AQLQ) Total Score", "description": "The AQLQ is a 32-item asthma specific questionnaire designed to measure functional impairments that are most important to patients with asthma, with a recall time of two weeks and each question to be answered on a 7-point scale, where 1=totally limited/problems all the time and 7= not at all limited/no problems. It consists of 4 domains: symptoms, activity limitation, emotional funtion, and emotional stimuli. The overall score is calculated as the mean of 32 items. Higher AQLQ scores indicate better health-related quality of life.", "timeFrame": "Baseline and Week 24"}], "secondaryOutcomes": [{"measure": "Change From Baseline in Trough Forced Expiratory Volume in 1 Second (FEV1)", "description": "FEV1 is the amount of air which can be forcibly exhaled from the lungs in the first second of a forced exhalation, measured through spirometry testing. Trough FEV1 is the mean of two FEV1 values measures taken 15 minutes (min) and 45 min prior to evening dose.", "timeFrame": "Baseline, Week 8, Week 16 and Week 24"}, {"measure": "Change From Baseline in Asthma Control Questionnaire (ACQ-7) Total Score", "description": "The ACQ-7 measured asthma symptom control and consists of 7 items: 5 on symptom assessment, 1 on rescue medication use and 1 on airway calibre (FEV1 % predicted). All seven items are scored on a 7-point Likert scale, with 0 indicating total control and 6 indicating poor control. The questions are equally weighted and the total score is the mean of the seven items. Higher score indicates worst symptoms. The first 6 questions of the ACQ-7 were completed by the participant while the last question was completed by the study investigator using data from the Master Scope spirometer. A negative change from baseline indicates improvement in lung function.", "timeFrame": "Baseline, Week 16 and Week 24"}, {"measure": "Change From Baseline in AQLQ Total Score", "description": "The AQLQ is a 32-item asthma specific questionnaire designed to measure functional impairments that are most important to patients with asthma, with a recall time of two weeks and each question to be answered on a 7-point scale, where 1=totally limited/problems all the time and 7= not at all limited/no problems. It consists of 4 domains: symptoms, activity limitation, emotional function and environmental stimuli. The overall score is calculated as the mean of 32 items. Higher AQLQ scores indicate better health-related quality of life.", "timeFrame": "Baseline and Week 16"}, {"measure": "Percentage of Patients Achieving the Minimally Clinically Important Difference (MCID) Decrease From Baseline ACQ-7 \u2265 0.5", "description": "The ACQ-7 measured asthma symptom control and consists of 7 items: 5 on symptom assessment, 1 on rescue medication use and 1 on airway calibre (FEV1 % predicted). All seven items are scored on a 7-point Likert scale, with 0 indicating total control and 6 indicating poor control. The questions are equally weighted and the total score is the mean of the seven items. Higher score indicates worst symptoms. The first 6 questions of the ACQ-7 were completed by the participant while the last question was completed by the study investigator using data from the Master Scope spirometer. A negative change from baseline indicates improvement in lung function. Decrease of ACQ-7 score of at least 0.5 from baseline was considered clinically meaningful.", "timeFrame": "Baseline and Week 24"}, {"measure": "Percentage of Patients Achieving the Minimally Clinically Important Difference (MCID) Change From Baseline AQLQ \u2265 0.5", "description": "The AQLQ is a 32-item asthma specific questionnaire designed to measure functional impairments that are most important to patients with asthma, with a recall time of two weeks and each question to be answered on a 7-point scale, where 1=totally limited/problems all the time and 7= not at all limited/no problems. It consists of 4 domains: symptoms, activity limitation, emotional function and environmental stimuli. The overall score is calculated as the mean of 32 items. Higher AQLQ scores indicate better health-related quality of life. An improvement of 0.5 points in AQLQ score is considered to be the minimally clinically important difference in asthma.", "timeFrame": "Baseline and Week 24"}, {"measure": "Change From Baseline in Forced Vital Capacity (FVC)", "description": "FVC is the total volume of air exhaled during a expiratory maneuvre. It was assessed by performing a spirometry assessment.", "timeFrame": "Baseline, Week 8, Week 16 and Week 24"}, {"measure": "Change From Baseline in Forced Expiratory Flow Between 25% and 75% of Forced Vital Capacity (FEF25-75)", "description": "Forced expiratory flow during the mid (25 - 75%) portion of the FVC. It was assessed by performing spirometric assessment.", "timeFrame": "Baseline, Week 8, Week 16 and Week 24"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with a diagnosis of asthma for a period of at least 6 months prior to Visit 1 with current asthma severity \u2265 step 4 (GINA 2017).\n* Patients who had used ICS/LABA combinations for asthma for at least 3 months and at stable medium or high dose of ICS/LABA for at least 1 month prior to Visit 1.\n* Patients were required to be symptomatic at screening despite treatment with medium or high stable doses of ICS/LABA as defined by ACQ-7 score \u2265 1.5 at visits 101 and 201 (randomization visit).\n* Patients with history of at least one severe asthma exacerbation which required medical care from a physician, emergency room visit (or local equivalent structure) or hospitalization in the 12 months prior to Visit 1 and required systemic corticosteroid treatment for at least 3 days including physician guided self-management treatment with oral corticosteroids as part of written asthma action plan.\n* Pre-bronchodilator FEV1 of \\< 85 % of the predicted normal value for the patient after withholding bronchodilators prior to spirometry at both Visit 101 and Visit 201.\n* Patients who demonstrated an increase in FEV1 of \u2265 12% and 200 ml.\n\nExclusion Criteria:\n\n* Patients who had a smoking history of greater than 20 pack years.\n* Patients diagnosed with Chronic Obstructive Pulmonary Disease (COPD).\n* Patients who had an asthma attack/exacerbation requiring systemic steroids or hospitalization or emergency room visit within 6 weeks of Visit 1 (Screening).\n* Patients treated with a LAMA for asthma within 3 months prior to Visit 1.\n* Patients who had a respiratory tract infection or clinical significant asthma worsening as defined by Investigator within 4 weeks prior to Visit 1 or between Visit 1 and Visit 201.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Novartis Pharmaceuticals", "affiliation": "Novartis Pharmaceuticals", "role": "STUDY_DIRECTOR"}], "locations": [{"facility": "Novartis Investigative Site", "city": "Berazategui", "state": "Buenos Aires", "zip": "1888", "country": "Argentina", "geoPoint": {"lat": -34.76531, "lon": -58.21278}}, {"facility": "Novartis Investigative Site", "city": "Caba", "state": "Buenos Aires", "zip": "C1122AAK", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Caba", "state": "Buenos Aires", "zip": "C1280AEB", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Caba", "state": "Buenos Aires", "zip": "C1414AIF", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Caba", "state": "Buenos Aires", "zip": "C1424BSF", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Caba", "state": "Buenos Aires", "zip": "C1425BEN", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Florida", "state": "Buenos Aires", "zip": "B1602DQD", "country": "Argentina"}, {"facility": "Novartis Investigative Site", "city": "Lanus", "state": "Buenos Aires", "zip": "B8000XAV", "country": "Argentina", "geoPoint": {"lat": -34.70252, "lon": -58.3955}}, {"facility": "Novartis Investigative Site", "city": "Mar del Plata", "state": "Buenos Aires", "zip": "7600", "country": "Argentina", "geoPoint": {"lat": -38.00228, "lon": -57.55754}}, {"facility": "Novartis Investigative Site", "city": "Nueve de Julio", "state": "Buenos Aires", "zip": "B6500EZL", "country": "Argentina", "geoPoint": {"lat": -35.44437, "lon": -60.88313}}, {"facility": "Novartis Investigative Site", "city": "Ranelagh, Partido De Berazate", "state": "Buenos Aires", "zip": "1884", "country": "Argentina"}, {"facility": "Novartis Investigative Site", "city": "Concepcion del Uruguay", "state": "Entre Rios", "zip": "3260", "country": "Argentina", "geoPoint": {"lat": -32.48249, "lon": -58.23722}}, {"facility": "Novartis Investigative Site", "city": "Santa Rosa", "state": "La Pampa", "zip": "6300", "country": "Argentina", "geoPoint": {"lat": -36.61667, "lon": -64.28333}}, {"facility": "Novartis Investigative Site", "city": "Buenos Aires", "state": "Nueve De Julio", "zip": "B6500BWQ", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Rosario", "state": "Santa Fe", "zip": "S2000AII", "country": "Argentina", "geoPoint": {"lat": -32.94682, "lon": -60.63932}}, {"facility": "Novartis Investigative Site", "city": "Rosario", "state": "Santa Fe", "zip": "S2000BRH", "country": "Argentina", "geoPoint": {"lat": -32.94682, "lon": -60.63932}}, {"facility": "Novartis Investigative Site", "city": "San Miguel de Tucuman", "state": "Tucuman", "zip": "4000", "country": "Argentina", "geoPoint": {"lat": -26.82414, "lon": -65.2226}}, {"facility": "Novartis Investigative Site", "city": "Bahia Blanca", "zip": "B8000JRB", "country": "Argentina", "geoPoint": {"lat": -38.71959, "lon": -62.27243}}, {"facility": "Novartis Investigative Site", "city": "Buenos Aires", "zip": "1900", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Buenos Aires", "zip": "B1646EBJ", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Buenos Aires", "zip": "C1125ABE", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Buenos Aires", "zip": "C1425FVH", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Ciudad Autonoma de Bs As", "zip": "C1128AAF", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Mendoza", "zip": "5500", "country": "Argentina", "geoPoint": {"lat": -32.89084, "lon": -68.82717}}, {"facility": "Novartis Investigative Site", "city": "Mendoza", "zip": "5501", "country": "Argentina", "geoPoint": {"lat": -32.89084, "lon": -68.82717}}, {"facility": "Novartis Investigative Site", "city": "Mendoza", "zip": "M5500CBA", "country": "Argentina", "geoPoint": {"lat": -32.89084, "lon": -68.82717}}, {"facility": "Novartis Investigative Site", "city": "Salta", "zip": "4400", "country": "Argentina", "geoPoint": {"lat": -24.7859, "lon": -65.41166}}, {"facility": "Novartis Investigative Site", "city": "Santa Fe", "zip": "S3000FIL", "country": "Argentina", "geoPoint": {"lat": -31.63333, "lon": -60.7}}, {"facility": "Novartis Investigative Site", "city": "Santiago", "state": "Region Metropolitana", "zip": "7500692", "country": "Chile", "geoPoint": {"lat": -33.45694, "lon": -70.64827}}, {"facility": "Novartis Investigative Site", "city": "Curico", "state": "VII Region Del Maule", "zip": "3341643", "country": "Chile", "geoPoint": {"lat": -34.98279, "lon": -71.23943}}, {"facility": "Novartis Investigative Site", "city": "Bogota", "state": "Cundinamarca", "zip": "110911", "country": "Colombia", "geoPoint": {"lat": 4.60971, "lon": -74.08175}}, {"facility": "Novartis Investigative Site", "city": "Bogota", "zip": "110221", "country": "Colombia", "geoPoint": {"lat": 4.60971, "lon": -74.08175}}, {"facility": "Novartis Investigative Site", "city": "Ostrava Poruba", "state": "Czech Republic", "zip": "708 68", "country": "Czechia", "geoPoint": {"lat": 49.83465, "lon": 18.28204}}, {"facility": "Novartis Investigative Site", "city": "Prague", "state": "Czech Republic", "zip": "169 00", "country": "Czechia", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"facility": "Novartis Investigative Site", "city": "Teplice", "state": "CZE", "zip": "415 01", "country": "Czechia", "geoPoint": {"lat": 50.6404, "lon": 13.82451}}, {"facility": "Novartis Investigative Site", "city": "Lovosice", "zip": "41002", "country": "Czechia", "geoPoint": {"lat": 50.51504, "lon": 14.05103}}, {"facility": "Novartis Investigative Site", "city": "Miroslav", "zip": "67172", "country": "Czechia", "geoPoint": {"lat": 48.94767, "lon": 16.31252}}, {"facility": "Novartis Investigative Site", "city": "Peine", "state": "Niedersachsen", "zip": "31224", "country": "Germany", "geoPoint": {"lat": 52.31928, "lon": 10.2352}}, {"facility": "Novartis Investigative Site", "city": "Geesthacht", "state": "Schleswig Holstein", "zip": "12502", "country": "Germany", "geoPoint": {"lat": 53.43575, "lon": 10.3779}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "10119", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "10625", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "10717", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "10969", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "12157", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "12159", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "12203", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "13086", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "13156", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "13187", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "14050", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Boehlen", "zip": "04564", "country": "Germany"}, {"facility": "Novartis Investigative Site", "city": "Bonn", "zip": "53123", "country": "Germany", "geoPoint": {"lat": 50.73438, "lon": 7.09549}}, {"facility": "Novartis Investigative Site", "city": "Darmstadt", "zip": "64283", "country": "Germany", "geoPoint": {"lat": 49.87167, "lon": 8.65027}}, {"facility": "Novartis Investigative Site", "city": "Dortmund", "zip": "44263", "country": "Germany", "geoPoint": {"lat": 51.51494, "lon": 7.466}}, {"facility": "Novartis Investigative Site", "city": "Einbeck", "zip": "37574", "country": "Germany", "geoPoint": {"lat": 51.82018, "lon": 9.86961}}, {"facility": "Novartis Investigative Site", "city": "Frankfurt", "zip": "60389", "country": "Germany", "geoPoint": {"lat": 50.11552, "lon": 8.68417}}, {"facility": "Novartis Investigative Site", "city": "Frankfurt", "zip": "60596", "country": "Germany", "geoPoint": {"lat": 50.11552, "lon": 8.68417}}, {"facility": "Novartis Investigative Site", "city": "Furstenwalde", "zip": "15517", "country": "Germany", "geoPoint": {"lat": 52.36067, "lon": 14.06185}}, {"facility": "Novartis Investigative Site", "city": "Gelsenkirchen", "zip": "45879", "country": "Germany", "geoPoint": {"lat": 51.50508, "lon": 7.09655}}, {"facility": "Novartis Investigative Site", "city": "Hamburg", "zip": "20354", "country": "Germany", "geoPoint": {"lat": 53.57532, "lon": 10.01534}}, {"facility": "Novartis Investigative Site", "city": "Hamburg", "zip": "22335", "country": "Germany", "geoPoint": {"lat": 53.57532, "lon": 10.01534}}, {"facility": "Novartis Investigative Site", "city": "Hannover", "zip": "30167", "country": "Germany", "geoPoint": {"lat": 52.37052, "lon": 9.73322}}, {"facility": "Novartis Investigative Site", "city": "Hannover", "zip": "30173", "country": "Germany", "geoPoint": {"lat": 52.37052, "lon": 9.73322}}, {"facility": "Novartis Investigative Site", "city": "Leipzig", "zip": "04103", "country": "Germany", "geoPoint": {"lat": 51.33962, "lon": 12.37129}}, {"facility": "Novartis Investigative Site", "city": "Leipzig", "zip": "04157", "country": "Germany", "geoPoint": {"lat": 51.33962, "lon": 12.37129}}, {"facility": "Novartis Investigative Site", "city": "Leipzig", "zip": "04275", "country": "Germany", "geoPoint": {"lat": 51.33962, "lon": 12.37129}}, {"facility": "Novartis Investigative Site", "city": "Leipzig", "zip": "04357", "country": "Germany", "geoPoint": {"lat": 51.33962, "lon": 12.37129}}, {"facility": "Novartis Investigative Site", "city": "Lubeck", "zip": "23552", "country": "Germany", "geoPoint": {"lat": 53.86893, "lon": 10.68729}}, {"facility": "Novartis Investigative Site", "city": "Ludwigsburg", "zip": "71640", "country": "Germany", "geoPoint": {"lat": 48.89731, "lon": 9.19161}}, {"facility": "Novartis Investigative Site", "city": "Marburg", "zip": "35037", "country": "Germany", "geoPoint": {"lat": 50.80904, "lon": 8.77069}}, {"facility": "Novartis Investigative Site", "city": "Marburg", "zip": "D-35037", "country": "Germany", "geoPoint": {"lat": 50.80904, "lon": 8.77069}}, {"facility": "Novartis Investigative Site", "city": "Menden", "zip": "58706", "country": "Germany", "geoPoint": {"lat": 51.44337, "lon": 7.77825}}, {"facility": "Novartis Investigative Site", "city": "Mittweida", "zip": "09648", "country": "Germany", "geoPoint": {"lat": 50.98622, "lon": 12.97537}}, {"facility": "Novartis Investigative Site", "city": "Munchen", "zip": "81241", "country": "Germany", "geoPoint": {"lat": 48.13743, "lon": 11.57549}}, {"facility": "Novartis Investigative Site", "city": "Potsdam", "zip": "14467", "country": "Germany", "geoPoint": {"lat": 52.39886, "lon": 13.06566}}, {"facility": "Novartis Investigative Site", "city": "Rudersdorf", "zip": "15562", "country": "Germany", "geoPoint": {"lat": 51.1, "lon": 11.45}}, {"facility": "Novartis Investigative Site", "city": "Schleswig", "zip": "24837", "country": "Germany", "geoPoint": {"lat": 54.52156, "lon": 9.5586}}, {"facility": "Novartis Investigative Site", "city": "Witten", "zip": "58452", "country": "Germany", "geoPoint": {"lat": 51.44362, "lon": 7.35258}}, {"facility": "Novartis Investigative Site", "city": "Athens", "state": "GR", "zip": "115 27", "country": "Greece", "geoPoint": {"lat": 37.97945, "lon": 23.71622}}, {"facility": "Novartis Investigative Site", "city": "Thessaloniki", "state": "GR", "zip": "546 03", "country": "Greece", "geoPoint": {"lat": 40.64361, "lon": 22.93086}}, {"facility": "Novartis Investigative Site", "city": "Thessaloniki", "state": "GR", "zip": "564 29", "country": "Greece", "geoPoint": {"lat": 40.64361, "lon": 22.93086}}, {"facility": "Novartis Investigative Site", "city": "Thessaloniki", "state": "GR", "zip": "570 10", "country": "Greece", "geoPoint": {"lat": 40.64361, "lon": 22.93086}}, {"facility": "Novartis Investigative Site", "city": "Athens", "zip": "12462", "country": "Greece", "geoPoint": {"lat": 37.97945, "lon": 23.71622}}, {"facility": "Novartis Investigative Site", "city": "Puspokladany", "state": "HUN", "zip": "4150", "country": "Hungary", "geoPoint": {"lat": 47.31667, "lon": 21.11667}}, {"facility": "Novartis Investigative Site", "city": "Balassagyarmat", "zip": "2660", "country": "Hungary", "geoPoint": {"lat": 48.07296, "lon": 19.29614}}, {"facility": "Novartis Investigative Site", "city": "Godollo", "zip": "2100", "country": "Hungary", "geoPoint": {"lat": 47.59657, "lon": 19.35515}}, {"facility": "Novartis Investigative Site", "city": "Komlo", "zip": "7300", "country": "Hungary", "geoPoint": {"lat": 46.19278, "lon": 18.26494}}, {"facility": "Novartis Investigative Site", "city": "Sellye", "zip": "7960", "country": "Hungary", "geoPoint": {"lat": 45.87247, "lon": 17.84711}}, {"facility": "Novartis Investigative Site", "city": "Siofok", "zip": "8600", "country": "Hungary", "geoPoint": {"lat": 46.90413, "lon": 18.058}}, {"facility": "Novartis Investigative Site", "city": "Szarvas", "zip": "5540", "country": "Hungary", "geoPoint": {"lat": 46.86667, "lon": 20.55}}, {"facility": "Novartis Investigative Site", "city": "Szeged", "zip": "6722", "country": "Hungary", "geoPoint": {"lat": 46.253, "lon": 20.14824}}, {"facility": "Novartis Investigative Site", "city": "Vijayawada", "state": "Andhra Pradesh", "zip": "520008", "country": "India", "geoPoint": {"lat": 16.50745, "lon": 80.6466}}, {"facility": "Novartis Investigative Site", "city": "Kozhikode", "state": "Kerala", "zip": "673008", "country": "India", "geoPoint": {"lat": 11.24802, "lon": 75.7804}}, {"facility": "Novartis Investigative Site", "city": "Nagpur", "state": "Maharashtra", "zip": "440019", "country": "India", "geoPoint": {"lat": 21.14631, "lon": 79.08491}}, {"facility": "Novartis Investigative Site", "city": "Pune", "state": "Maharashtra", "zip": "411014", "country": "India", "geoPoint": {"lat": 18.51957, "lon": 73.85535}}, {"facility": "Novartis Investigative Site", "city": "Mohali", "state": "Punjab", "zip": "160 062", "country": "India", "geoPoint": {"lat": 30.67995, "lon": 76.72211}}, {"facility": "Novartis Investigative Site", "city": "Coimbatore", "state": "Tamil Nadu", "zip": "641 045", "country": "India", "geoPoint": {"lat": 11.00555, "lon": 76.96612}}, {"facility": "Novartis Investigative Site", "city": "Vellore", "state": "Tamil Nadu", "zip": "632004", "country": "India", "geoPoint": {"lat": 12.9184, "lon": 79.13255}}, {"facility": "Novartis Investigative Site", "city": "Hyderabad", "state": "Telangana", "zip": "500 038", "country": "India", "geoPoint": {"lat": 17.38405, "lon": 78.45636}}, {"facility": "Novartis Investigative Site", "city": "Kolkata", "state": "West Bengal", "zip": "700 107", "country": "India", "geoPoint": {"lat": 22.56263, "lon": 88.36304}}, {"facility": "Novartis Investigative Site", "city": "Jerusalem", "zip": "91031", "country": "Israel", "geoPoint": {"lat": 31.76904, "lon": 35.21633}}, {"facility": "Novartis Investigative Site", "city": "Jerusalem", "zip": "91120", "country": "Israel", "geoPoint": {"lat": 31.76904, "lon": 35.21633}}, {"facility": "Novartis Investigative Site", "city": "Ramat Gan", "zip": "5266202", "country": "Israel", "geoPoint": {"lat": 32.08227, "lon": 34.81065}}, {"facility": "Novartis Investigative Site", "city": "Rehovot", "zip": "76100", "country": "Israel", "geoPoint": {"lat": 31.89421, "lon": 34.81199}}, {"facility": "Novartis Investigative Site", "city": "Mexico", "state": "Distrito Federal", "zip": "14050", "country": "Mexico", "geoPoint": {"lat": 19.42847, "lon": -99.12766}}, {"facility": "Novartis Investigative Site", "city": "Guadalajara", "state": "Jalisco", "zip": "44100", "country": "Mexico", "geoPoint": {"lat": 20.66682, "lon": -103.39182}}, {"facility": "Novartis Investigative Site", "city": "Guadalajara", "state": "Jalisco", "zip": "44160", "country": "Mexico", "geoPoint": {"lat": 20.66682, "lon": -103.39182}}, {"facility": "Novartis Investigative Site", "city": "San Martin de Porres", "state": "Lima", "zip": "31", "country": "Peru"}, {"facility": "Novartis Investigative Site", "city": "Santiago de Surco", "state": "Lima", "zip": "33", "country": "Peru", "geoPoint": {"lat": -12.13588, "lon": -77.00742}}, {"facility": "Novartis Investigative Site", "city": "Cusco", "zip": "84", "country": "Peru", "geoPoint": {"lat": -13.52264, "lon": -71.96734}}, {"facility": "Novartis Investigative Site", "city": "Lima", "zip": "1", "country": "Peru", "geoPoint": {"lat": -12.04318, "lon": -77.02824}}, {"facility": "Novartis Investigative Site", "city": "Katowice", "zip": "40-648", "country": "Poland", "geoPoint": {"lat": 50.25841, "lon": 19.02754}}, {"facility": "Novartis Investigative Site", "city": "Poznan", "zip": "60 823", "country": "Poland", "geoPoint": {"lat": 52.40692, "lon": 16.92993}}, {"facility": "Novartis Investigative Site", "city": "Poznan", "zip": "60-214", "country": "Poland", "geoPoint": {"lat": 52.40692, "lon": 16.92993}}, {"facility": "Novartis Investigative Site", "city": "Poznan", "zip": "60-693", "country": "Poland", "geoPoint": {"lat": 52.40692, "lon": 16.92993}}, {"facility": "Novartis Investigative Site", "city": "Izhevsk", "zip": "426061", "country": "Russian Federation", "geoPoint": {"lat": 56.84976, "lon": 53.20448}}, {"facility": "Novartis Investigative Site", "city": "Kemerovo", "zip": "650002", "country": "Russian Federation", "geoPoint": {"lat": 55.33333, "lon": 86.08333}}, {"facility": "Novartis Investigative Site", "city": "Moscow", "zip": "105275", "country": "Russian Federation", "geoPoint": {"lat": 55.75222, "lon": 37.61556}}, {"facility": "Novartis Investigative Site", "city": "Moscow", "zip": "109544", "country": "Russian Federation", "geoPoint": {"lat": 55.75222, "lon": 37.61556}}, {"facility": "Novartis Investigative Site", "city": "Moscow", "zip": "123423", "country": "Russian Federation", "geoPoint": {"lat": 55.75222, "lon": 37.61556}}, {"facility": "Novartis Investigative Site", "city": "Nizhny Novgorod", "zip": "603018", "country": "Russian Federation", "geoPoint": {"lat": 56.32867, "lon": 44.00205}}, {"facility": "Novartis Investigative Site", "city": "Novosibirsk", "zip": "630102", "country": "Russian Federation", "geoPoint": {"lat": 55.0415, "lon": 82.9346}}, {"facility": "Novartis Investigative Site", "city": "Saint Petersburg", "zip": "107022", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "Saint Petersburg", "zip": "194354", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "Saint Petersburg", "zip": "195271", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "Saint Petersburg", "zip": "197022", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "Saint-Petersburg", "zip": "191186", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "Saint-Petersburg", "zip": "196143", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "Saratov", "zip": "410028", "country": "Russian Federation", "geoPoint": {"lat": 51.54056, "lon": 46.00861}}, {"facility": "Novartis Investigative Site", "city": "Saratov", "zip": "410054", "country": "Russian Federation", "geoPoint": {"lat": 51.54056, "lon": 46.00861}}, {"facility": "Novartis Investigative Site", "city": "St Petersburg", "zip": "193312", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "Ulyanovsk", "zip": "432063", "country": "Russian Federation", "geoPoint": {"lat": 54.32824, "lon": 48.38657}}, {"facility": "Novartis Investigative Site", "city": "Yekaterinburg", "zip": "620109", "country": "Russian Federation", "geoPoint": {"lat": 56.8519, "lon": 60.6122}}, {"facility": "Novartis Investigative Site", "city": "Belgrade", "zip": "11000", "country": "Serbia", "geoPoint": {"lat": 44.80401, "lon": 20.46513}}, {"facility": "Novartis Investigative Site", "city": "Kragujevac", "zip": "34000", "country": "Serbia", "geoPoint": {"lat": 44.01667, "lon": 20.91667}}, {"facility": "Novartis Investigative Site", "city": "Nis", "zip": "18000", "country": "Serbia", "geoPoint": {"lat": 43.32472, "lon": 21.90333}}, {"facility": "Novartis Investigative Site", "city": "Sremska Kamenica", "zip": "21204", "country": "Serbia", "geoPoint": {"lat": 45.22158, "lon": 19.84367}}, {"facility": "Novartis Investigative Site", "city": "Bojnice", "state": "Slovak Republic", "zip": "972 01", "country": "Slovakia", "geoPoint": {"lat": 48.78511, "lon": 18.5864}}, {"facility": "Novartis Investigative Site", "city": "Humenne", "state": "Slovak Republic", "zip": "066 01", "country": "Slovakia", "geoPoint": {"lat": 48.93707, "lon": 21.91625}}, {"facility": "Novartis Investigative Site", "city": "Liptovsky Hradok", "state": "Slovak Republic", "zip": "033 01", "country": "Slovakia", "geoPoint": {"lat": 49.03962, "lon": 19.72335}}, {"facility": "Novartis Investigative Site", "city": "Liptovsky Mikulas", "zip": "031 23", "country": "Slovakia", "geoPoint": {"lat": 49.08061, "lon": 19.62218}}, {"facility": "Novartis Investigative Site", "city": "Topolcany", "zip": "95501", "country": "Slovakia", "geoPoint": {"lat": 48.56361, "lon": 18.16712}}, {"facility": "Novartis Investigative Site", "city": "Zilina", "zip": "01001", "country": "Slovakia", "geoPoint": {"lat": 49.22315, "lon": 18.73941}}, {"facility": "Novartis Investigative Site", "city": "Berea", "state": "Durban", "zip": "4001", "country": "South Africa", "geoPoint": {"lat": -29.85185, "lon": 30.99337}}, {"facility": "Novartis Investigative Site", "city": "Cape Town", "zip": "7530", "country": "South Africa", "geoPoint": {"lat": -33.92584, "lon": 18.42322}}, {"facility": "Novartis Investigative Site", "city": "Cape Town", "zip": "7700", "country": "South Africa", "geoPoint": {"lat": -33.92584, "lon": 18.42322}}, {"facility": "Novartis Investigative Site", "city": "Chatsworth", "zip": "4092", "country": "South Africa", "geoPoint": {"lat": -33.54778, "lon": 18.58201}}, {"facility": "Novartis Investigative Site", "city": "Kempton Park", "zip": "1619", "country": "South Africa", "geoPoint": {"lat": -26.10859, "lon": 28.2377}}, {"facility": "Novartis Investigative Site", "city": "Pretoria", "zip": "0183", "country": "South Africa", "geoPoint": {"lat": -25.74486, "lon": 28.18783}}, {"facility": "Novartis Investigative Site", "city": "Esparraguera", "state": "Barcelona", "zip": "08292", "country": "Spain", "geoPoint": {"lat": 41.53809, "lon": 1.87025}}, {"facility": "Novartis Investigative Site", "city": "Hostalets De Balenya", "state": "Cataluna", "zip": "08550", "country": "Spain"}, {"facility": "Novartis Investigative Site", "city": "Alzira", "state": "Comunidad Valenciana", "zip": "46600", "country": "Spain", "geoPoint": {"lat": 39.15, "lon": -0.43333}}, {"facility": "Novartis Investigative Site", "city": "Caceres", "state": "Extremadura", "zip": "10003", "country": "Spain", "geoPoint": {"lat": 39.47649, "lon": -6.37224}}, {"facility": "Novartis Investigative Site", "city": "Benalmadena", "state": "Malaga", "zip": "29639", "country": "Spain", "geoPoint": {"lat": 36.5961, "lon": -4.57267}}, {"facility": "Novartis Investigative Site", "city": "Kaoshiung", "zip": "80756", "country": "Taiwan"}, {"facility": "Novartis Investigative Site", "city": "Taichung", "zip": "40447", "country": "Taiwan", "geoPoint": {"lat": 24.1469, "lon": 120.6839}}, {"facility": "Novartis Investigative Site", "city": "Taipei", "zip": "10449", "country": "Taiwan", "geoPoint": {"lat": 25.04776, "lon": 121.53185}}, {"facility": "Novartis Investigative Site", "city": "Izmir", "zip": "35040", "country": "Turkey", "geoPoint": {"lat": 38.41273, "lon": 27.13838}}, {"facility": "Novartis Investigative Site", "city": "Mersin", "zip": "33343", "country": "Turkey", "geoPoint": {"lat": 36.79526, "lon": 34.61792}}, {"facility": "Novartis Investigative Site", "city": "Yenisehir/Izmir", "zip": "35110", "country": "Turkey"}, {"facility": "Novartis Investigative Site", "city": "Ho Chi Minh", "state": "VNM", "zip": "700000", "country": "Vietnam", "geoPoint": {"lat": 10.82302, "lon": 106.62965}}, {"facility": "Novartis Investigative Site", "city": "Hanoi", "zip": "100000", "country": "Vietnam", "geoPoint": {"lat": 21.0245, "lon": 105.84117}}, {"facility": "Novartis Investigative Site", "city": "Ho Chi Minh", "zip": "700000", "country": "Vietnam", "geoPoint": {"lat": 10.82302, "lon": 106.62965}}]}, "referencesModule": {"seeAlsoLinks": [{"label": "A Plain Language Trial Summary is available on novartisclinicaltrials.com", "url": "https://www.novctrd.com/ctrdweb/patientsummary/patientsummaries?patientSummaryId=657"}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "A total of 1917 participants were screened. A 2 week run-in phase preceded the randomized treatment phase of the study. 1821 participants entered the run-in phase. Those participants who met the inclusion criteria entered the randomized treatment phase. Participants were randomized with a randomization ratio of 1:1:1 to three treatment arms.", "recruitmentDetails": "Participants took part in 166 investigative sites in 20 countries from 05 Feb 2018 to 19 Jul 2019.", "groups": [{"id": "FG000", "title": "QVM149 150/50/80 \u03bcg", "description": "QVM149 150/50/80 \u03bcg o.d. delivered via Concept1"}, {"id": "FG001", "title": "QVM149 150/50/160 \u03bcg", "description": "QVM149 150/50/160 \u03bcg o.d. delivered via Concept1"}, {"id": "FG002", "title": "Salmeterol/Fluticasone 50/500 \u03bcg Plus Tiotropium 5 \u03bcg", "description": "Salmeterol/fluticasone 50/500 \u03bcg b.i.d. delivered via Accuhaler\u00ae plus tiotropium 5 \u03bcg o.d. delivered via Respimat\u00ae"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "comment": "All participants who were assigned a randomization number", "achievements": [{"groupId": "FG000", "numSubjects": "474"}, {"groupId": "FG001", "numSubjects": "476"}, {"groupId": "FG002", "numSubjects": "476"}]}, {"type": "Full Analysis Set (FAS)", "comment": "All the participants in the randomization set who received at least one dose of the study medication", "achievements": [{"groupId": "FG000", "numSubjects": "474"}, {"groupId": "FG001", "numSubjects": "476"}, {"groupId": "FG002", "numSubjects": "475"}]}, {"type": "Safety Set (SAF)", "comment": "All the participants who received at least one dose of the study medication", "achievements": [{"groupId": "FG000", "numSubjects": "474"}, {"groupId": "FG001", "numSubjects": "476"}, {"groupId": "FG002", "numSubjects": "475"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "452"}, {"groupId": "FG001", "numSubjects": "460"}, {"groupId": "FG002", "numSubjects": "448"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "22"}, {"groupId": "FG001", "numSubjects": "16"}, {"groupId": "FG002", "numSubjects": "28"}]}], "dropWithdraws": [{"type": "Subject/Guardian Decision", "reasons": [{"groupId": "FG000", "numSubjects": "10"}, {"groupId": "FG001", "numSubjects": "6"}, {"groupId": "FG002", "numSubjects": "11"}]}, {"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "5"}, {"groupId": "FG001", "numSubjects": "3"}, {"groupId": "FG002", "numSubjects": "3"}]}, {"type": "Techinical Problems", "reasons": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "5"}]}, {"type": "Physician Decision", "reasons": [{"groupId": "FG000", "numSubjects": "2"}, {"groupId": "FG001", "numSubjects": "3"}, {"groupId": "FG002", "numSubjects": "7"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "1"}]}, {"type": "Sponsor decision", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}]}, {"type": "Pregnancy", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "2"}, {"groupId": "FG002", "numSubjects": "0"}]}, {"type": "Randomized in error", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "1"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "QVM149 150/50/80 \u03bcg", "description": "QVM149 150/50/80 \u03bcg o.d. delivered via Concept1"}, {"id": "BG001", "title": "QVM149 150/50/160 \u03bcg", "description": "QVM149 150/50/160 \u03bcg o.d. delivered via Concept1"}, {"id": "BG002", "title": "Salmeterol/Fluticasone 50/500 \u03bcg Plus Tiotropium 5 \u03bcg", "description": "Salmeterol/fluticasone 50/500 \u03bcg b.i.d. delivered via Accuhaler\u00ae plus tiotropium 5 \u03bcg o.d. delivered via Respimat\u00ae"}, {"id": "BG003", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "474"}, {"groupId": "BG001", "value": "476"}, {"groupId": "BG002", "value": "476"}, {"groupId": "BG003", "value": "1426"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "51.9", "spread": "13.58"}, {"groupId": "BG001", "value": "52.7", "spread": "13.34"}, {"groupId": "BG002", "value": "53.1", "spread": "13.08"}, {"groupId": "BG003", "value": "52.5", "spread": "13.33"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "306"}, {"groupId": "BG001", "value": "289"}, {"groupId": "BG002", "value": "307"}, {"groupId": "BG003", "value": "902"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "168"}, {"groupId": "BG001", "value": "187"}, {"groupId": "BG002", "value": "169"}, {"groupId": "BG003", "value": "524"}]}]}]}, {"title": "Race/Ethnicity, Customized", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "5"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "10"}, {"groupId": "BG003", "value": "16"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "36"}, {"groupId": "BG001", "value": "34"}, {"groupId": "BG002", "value": "33"}, {"groupId": "BG003", "value": "103"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "6"}, {"groupId": "BG001", "value": "5"}, {"groupId": "BG002", "value": "3"}, {"groupId": "BG003", "value": "14"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "401"}, {"groupId": "BG001", "value": "392"}, {"groupId": "BG002", "value": "391"}, {"groupId": "BG003", "value": "1184"}]}, {"title": "Other", "measurements": [{"groupId": "BG000", "value": "26"}, {"groupId": "BG001", "value": "44"}, {"groupId": "BG002", "value": "39"}, {"groupId": "BG003", "value": "109"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Change From Baseline in Asthma Quality of Life Questionnaire (AQLQ) Total Score", "description": "The AQLQ is a 32-item asthma specific questionnaire designed to measure functional impairments that are most important to patients with asthma, with a recall time of two weeks and each question to be answered on a 7-point scale, where 1=totally limited/problems all the time and 7= not at all limited/no problems. It consists of 4 domains: symptoms, activity limitation, emotional funtion, and emotional stimuli. The overall score is calculated as the mean of 32 items. Higher AQLQ scores indicate better health-related quality of life.", "populationDescription": "Analysis population included FAS with evaluable AQLQ data at both timepoints. No imputation was used for missing questions or missing total AQLQ score for this analysis. The analysis was performed on observed data only.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Score on a scale", "timeFrame": "Baseline and Week 24", "groups": [{"id": "OG000", "title": "QVM149 150/50/80 \u03bcg", "description": "QVM149 150/50/80 \u03bcg o.d. delivered via Concept1"}, {"id": "OG001", "title": "QVM149 150/50/160 \u03bcg", "description": "QVM149 150/50/160 \u03bcg o.d. delivered via Concept1"}, {"id": "OG002", "title": "Salmeterol/Fluticasone 50/500 \u03bcg Plus Tiotropium 5 \u03bcg", "description": "Salmeterol/fluticasone 50/500 \u03bcg b.i.d. delivered via Accuhaler\u00ae plus tiotropium 5 \u03bcg o.d. delivered via Respimat\u00ae"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "436"}, {"groupId": "OG001", "value": "453"}, {"groupId": "OG002", "value": "435"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.715", "spread": "0.070"}, {"groupId": "OG001", "value": "0.827", "spread": "0.069"}, {"groupId": "OG002", "value": "0.753", "spread": "0.069"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "nonInferiorityType": "NON_INFERIORITY", "nonInferiorityComment": "Non-inferiority margin: 0.25 points", "pValue": "<0.001", "pValueComment": "P-Value is one-sided", "statisticalMethod": "Mixed Model for Repeated Measures (MMRM)", "paramType": "Least Square mean (LS Mean)", "paramValue": "-0.038", "ciPctValue": "97.5", "ciNumSides": "ONE_SIDED", "ciLowerLimit": "-0.139", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.051"}, {"groupIds": ["OG001", "OG002"], "nonInferiorityType": "NON_INFERIORITY", "nonInferiorityComment": "Non-inferiority margin: 0.25 points", "pValue": "<0.001", "pValueComment": "P-Value is one-sided", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.073", "ciPctValue": "97.5", "ciNumSides": "ONE_SIDED", "ciLowerLimit": "-0.027", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.051"}]}, {"type": "SECONDARY", "title": "Change From Baseline in Trough Forced Expiratory Volume in 1 Second (FEV1)", "description": "FEV1 is the amount of air which can be forcibly exhaled from the lungs in the first second of a forced exhalation, measured through spirometry testing. Trough FEV1 is the mean of two FEV1 values measures taken 15 minutes (min) and 45 min prior to evening dose.", "populationDescription": "Analysis population included FAS with FEV1 data at the respective visit. Number analyzed signified number of participants who were evaluable for this outcome measure at specified timepoints.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Litre (L)", "timeFrame": "Baseline, Week 8, Week 16 and Week 24", "groups": [{"id": "OG000", "title": "QVM149 150/50/80 \u03bcg", "description": "QVM149 150/50/80 \u03bcg o.d. delivered via Concept1"}, {"id": "OG001", "title": "QVM149 150/50/160 \u03bcg", "description": "QVM149 150/50/160 \u03bcg o.d. delivered via Concept1"}, {"id": "OG002", "title": "Salmeterol/Fluticasone 50/500 \u03bcg Plus Tiotropium 5 \u03bcg", "description": "Salmeterol/fluticasone 50/500 \u03bcg b.i.d. delivered via Accuhaler\u00ae plus tiotropium 5 \u03bcg o.d. delivered via Respimat\u00ae"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "420"}, {"groupId": "OG001", "value": "438"}, {"groupId": "OG002", "value": "425"}]}], "classes": [{"title": "Week 8", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "382"}, {"groupId": "OG001", "value": "395"}, {"groupId": "OG002", "value": "371"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.246", "spread": "0.020"}, {"groupId": "OG001", "value": "0.309", "spread": "0.020"}, {"groupId": "OG002", "value": "0.243", "spread": "0.020"}]}]}, {"title": "Week 16", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "357"}, {"groupId": "OG001", "value": "389"}, {"groupId": "OG002", "value": "371"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.251", "spread": "0.020"}, {"groupId": "OG001", "value": "0.319", "spread": "0.020"}, {"groupId": "OG002", "value": "0.253", "spread": "0.020"}]}]}, {"title": "Week 24", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "367"}, {"groupId": "OG001", "value": "385"}, {"groupId": "OG002", "value": "372"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.248", "spread": "0.021"}, {"groupId": "OG001", "value": "0.334", "spread": "0.021"}, {"groupId": "OG002", "value": "0.238", "spread": "0.021"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "Week 8", "nonInferiorityType": "SUPERIORITY", "pValue": "0.892", "pValueComment": "P-value is two-sided", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.003", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.046", "ciUpperLimit": "0.052", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.025"}, {"groupIds": ["OG001", "OG002"], "groupDescription": "Week 8", "nonInferiorityType": "SUPERIORITY", "pValue": "0.007", "pValueComment": "P-value is two-sided", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.067", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.018", "ciUpperLimit": "0.115", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.025"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Week 16", "nonInferiorityType": "SUPERIORITY", "pValue": "0.945", "pValueComment": "P-value is two-sided", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "-0.002", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.050", "ciUpperLimit": "0.047", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.025"}, {"groupIds": ["OG001", "OG002"], "groupDescription": "Week 16", "nonInferiorityType": "SUPERIORITY", "pValue": "0.007", "pValueComment": "P-value is two-sided", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.066", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.018", "ciUpperLimit": "0.114", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.025"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Week 24", "nonInferiorityType": "SUPERIORITY", "pValue": "0.713", "pValueComment": "P-value is two-sided", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.009", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.041", "ciUpperLimit": "0.060", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.026"}, {"groupIds": ["OG001", "OG002"], "groupDescription": "Week 24", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "pValueComment": "P-value is two-sided", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.096", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.046", "ciUpperLimit": "0.146", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.026"}]}, {"type": "SECONDARY", "title": "Change From Baseline in Asthma Control Questionnaire (ACQ-7) Total Score", "description": "The ACQ-7 measured asthma symptom control and consists of 7 items: 5 on symptom assessment, 1 on rescue medication use and 1 on airway calibre (FEV1 % predicted). All seven items are scored on a 7-point Likert scale, with 0 indicating total control and 6 indicating poor control. The questions are equally weighted and the total score is the mean of the seven items. Higher score indicates worst symptoms. The first 6 questions of the ACQ-7 were completed by the participant while the last question was completed by the study investigator using data from the Master Scope spirometer. A negative change from baseline indicates improvement in lung function.", "populationDescription": "Analysis population included FAS with ACQ-7 data at the respective visit. Number analyzed signified number of participants who were evaluable for this measure at specified timepoints. No imputation was used for missing questions or missing total ACQ-7 score for this analysis. The analysis was performed on observed data only", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Score on a scale", "timeFrame": "Baseline, Week 16 and Week 24", "groups": [{"id": "OG000", "title": "QVM149 150/50/80 \u03bcg", "description": "QVM149 150/50/80 \u03bcg o.d. delivered via Concept1"}, {"id": "OG001", "title": "QVM149 150/50/160 \u03bcg", "description": "QVM149 150/50/160 \u03bcg o.d. delivered via Concept1"}, {"id": "OG002", "title": "Salmeterol/Fluticasone 50/500 \u03bcg Plus Tiotropium 5 \u03bcg", "description": "Salmeterol/fluticasone 50/500 \u03bcg b.i.d. delivered via Accuhaler\u00ae plus tiotropium 5 \u03bcg o.d. delivered via Respimat\u00ae"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "447"}, {"groupId": "OG001", "value": "454"}, {"groupId": "OG002", "value": "447"}]}], "classes": [{"title": "Week 16", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "436"}, {"groupId": "OG001", "value": "441"}, {"groupId": "OG002", "value": "428"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.043", "spread": "0.045"}, {"groupId": "OG001", "value": "-1.098", "spread": "0.045"}, {"groupId": "OG002", "value": "-1.020", "spread": "0.045"}]}]}, {"title": "Week 24", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "437"}, {"groupId": "OG001", "value": "452"}, {"groupId": "OG002", "value": "436"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.080", "spread": "0.046"}, {"groupId": "OG001", "value": "-1.172", "spread": "0.045"}, {"groupId": "OG002", "value": "-1.048", "spread": "0.046"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "Week 16", "nonInferiorityType": "SUPERIORITY", "pValue": "0.308", "pValueComment": "P-value is one-sided", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "-0.023", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.113", "ciUpperLimit": "0.067", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.046"}, {"groupIds": ["OG001", "OG002"], "groupDescription": "Week 16", "nonInferiorityType": "SUPERIORITY", "pValue": "0.044", "pValueComment": "P-value is one-sided", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "-0.079", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.169", "ciUpperLimit": "0.012", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.046"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Week 24", "nonInferiorityType": "SUPERIORITY", "pValue": "0.245", "pValueComment": "P-value is one sided", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "-0.032", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.125", "ciUpperLimit": "0.060", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.047"}, {"groupIds": ["OG001", "OG002"], "groupDescription": "Week 24", "nonInferiorityType": "SUPERIORITY", "pValue": "0.004", "pValueComment": "P-value is one sided", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "-0.124", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.216", "ciUpperLimit": "-0.032", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.047"}]}, {"type": "SECONDARY", "title": "Change From Baseline in AQLQ Total Score", "description": "The AQLQ is a 32-item asthma specific questionnaire designed to measure functional impairments that are most important to patients with asthma, with a recall time of two weeks and each question to be answered on a 7-point scale, where 1=totally limited/problems all the time and 7= not at all limited/no problems. It consists of 4 domains: symptoms, activity limitation, emotional function and environmental stimuli. The overall score is calculated as the mean of 32 items. Higher AQLQ scores indicate better health-related quality of life.", "populationDescription": "Analysis population included FAS with evaluable AQLQ data at both timepoints. No imputation was used for missing questions or missing total AQLQ score for this analysis. The analysis was performed on observed data only", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Score on a scale", "timeFrame": "Baseline and Week 16", "groups": [{"id": "OG000", "title": "QVM149 150/50/80 \u03bcg", "description": "QVM149 150/50/80 \u03bcg o.d. delivered via Concept1"}, {"id": "OG001", "title": "QVM149 150/50/160 \u03bcg", "description": "QVM149 150/50/160 \u03bcg o.d. delivered via Concept1"}, {"id": "OG002", "title": "Salmeterol/Fluticasone 50/500 \u03bcg Plus Tiotropium 5 \u03bcg", "description": "Salmeterol/fluticasone 50/500 \u03bcg b.i.d. delivered via Accuhaler\u00ae plus tiotropium 5 \u03bcg o.d. delivered via Respimat\u00ae"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "435"}, {"groupId": "OG001", "value": "442"}, {"groupId": "OG002", "value": "429"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.690", "spread": "0.069"}, {"groupId": "OG001", "value": "0.755", "spread": "0.068"}, {"groupId": "OG002", "value": "0.673", "spread": "0.069"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.719", "pValueComment": "P-value is two-sided", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.018", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.079", "ciUpperLimit": "0.115", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.049"}, {"groupIds": ["OG001", "OG002"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.097", "pValueComment": "P-value is two-sided", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.082", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.015", "ciUpperLimit": "0.179", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.049"}]}, {"type": "SECONDARY", "title": "Percentage of Patients Achieving the Minimally Clinically Important Difference (MCID) Decrease From Baseline ACQ-7 \u2265 0.5", "description": "The ACQ-7 measured asthma symptom control and consists of 7 items: 5 on symptom assessment, 1 on rescue medication use and 1 on airway calibre (FEV1 % predicted). All seven items are scored on a 7-point Likert scale, with 0 indicating total control and 6 indicating poor control. The questions are equally weighted and the total score is the mean of the seven items. Higher score indicates worst symptoms. The first 6 questions of the ACQ-7 were completed by the participant while the last question was completed by the study investigator using data from the Master Scope spirometer. A negative change from baseline indicates improvement in lung function. Decrease of ACQ-7 score of at least 0.5 from baseline was considered clinically meaningful.", "populationDescription": "Analysis population included FAS with evaluable ACQ-7 data at both timepoints. Missing data imputation was used to perform this analysis. Subjects with missing values were imputed as non-responders (a non-responder was defined as \\<0.5 decrease in ACQ-7 score at week 24)", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Baseline and Week 24", "groups": [{"id": "OG000", "title": "QVM149 150/50/80 \u03bcg", "description": "QVM149 150/50/80 \u03bcg o.d. delivered via Concept1"}, {"id": "OG001", "title": "QVM149 150/50/160 \u03bcg", "description": "QVM149 150/50/160 \u03bcg o.d. delivered via Concept1"}, {"id": "OG002", "title": "Salmeterol/Fluticasone 50/500 \u03bcg Plus Tiotropium 5 \u03bcg", "description": "Salmeterol/fluticasone 50/500 \u03bcg b.i.d. delivered via Accuhaler\u00ae plus tiotropium 5 \u03bcg o.d. delivered via Respimat\u00ae"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "447"}, {"groupId": "OG001", "value": "454"}, {"groupId": "OG002", "value": "447"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "393"}, {"groupId": "OG001", "value": "387"}, {"groupId": "OG002", "value": "375"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.061", "pValueComment": "P-value is one sided", "statisticalMethod": "Regression, Logistic", "statisticalComment": "Logistic Regression Model via Generalized estimating equations (GEE)", "paramType": "Odds Ratio (OR)", "paramValue": "1.23", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.94", "ciUpperLimit": "1.61"}, {"groupIds": ["OG001", "OG002"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.227", "pValueComment": "P-value is one-sided", "statisticalMethod": "Regression, Logistic", "statisticalComment": "Logistic Regression Model via GEE", "paramType": "Odds Ratio (OR)", "paramValue": "1.11", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.85", "ciUpperLimit": "1.46"}]}, {"type": "SECONDARY", "title": "Percentage of Patients Achieving the Minimally Clinically Important Difference (MCID) Change From Baseline AQLQ \u2265 0.5", "description": "The AQLQ is a 32-item asthma specific questionnaire designed to measure functional impairments that are most important to patients with asthma, with a recall time of two weeks and each question to be answered on a 7-point scale, where 1=totally limited/problems all the time and 7= not at all limited/no problems. It consists of 4 domains: symptoms, activity limitation, emotional function and environmental stimuli. The overall score is calculated as the mean of 32 items. Higher AQLQ scores indicate better health-related quality of life. An improvement of 0.5 points in AQLQ score is considered to be the minimally clinically important difference in asthma.", "populationDescription": "Analysis population included FAS with evaluable AQLQ data at both timepoints. Missing data imputation was used to perform this analysis. Subjects with missing values were imputed as non-responders (a non-responder was defined as \\<0.5 increase in AQLQ score at week 24)", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Baseline and Week 24", "groups": [{"id": "OG000", "title": "QVM149 150/50/80 \u03bcg", "description": "QVM149 150/50/80 \u03bcg o.d. delivered via Concept1"}, {"id": "OG001", "title": "QVM149 150/50/160 \u03bcg", "description": "QVM149 150/50/160 \u03bcg o.d. delivered via Concept1"}, {"id": "OG002", "title": "Salmeterol/Fluticasone 50/500 \u03bcg Plus Tiotropium 5 \u03bcg", "description": "Salmeterol/fluticasone 50/500 \u03bcg b.i.d. delivered via Accuhaler\u00ae plus tiotropium 5 \u03bcg o.d. delivered via Respimat\u00ae"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "444"}, {"groupId": "OG001", "value": "454"}, {"groupId": "OG002", "value": "441"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "318"}, {"groupId": "OG001", "value": "333"}, {"groupId": "OG002", "value": "299"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.108", "pValueComment": "P-value is one sided", "statisticalMethod": "Regression, Logistic", "statisticalComment": "Logistic regression model via the GEE", "paramType": "Odds Ratio (OR)", "paramValue": "1.17", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.91", "ciUpperLimit": "1.49"}, {"groupIds": ["OG001", "OG002"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.013", "pValueComment": "P-Value is one sided", "statisticalMethod": "Regression, Logistic", "statisticalComment": "Logistic regression model via the GEE", "paramType": "Odds Ratio (OR)", "paramValue": "1.33", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "1.03", "ciUpperLimit": "1.70"}]}, {"type": "SECONDARY", "title": "Change From Baseline in Forced Vital Capacity (FVC)", "description": "FVC is the total volume of air exhaled during a expiratory maneuvre. It was assessed by performing a spirometry assessment.", "populationDescription": "Analysis population included FAS with FVC data at the respective visit. Number analyzed signified number of participants who were evaluable for this measure at specified timepoints.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Litre (L)", "timeFrame": "Baseline, Week 8, Week 16 and Week 24", "groups": [{"id": "OG000", "title": "QVM149 150/50/80 \u03bcg", "description": "QVM149 150/50/80 \u03bcg o.d. delivered via Concept1"}, {"id": "OG001", "title": "QVM149 150/50/160 \u03bcg", "description": "QVM149 150/50/160 \u03bcg o.d. delivered via Concept1"}, {"id": "OG002", "title": "Salmeterol/Fluticasone 50/500 \u03bcg Plus Tiotropium 5 \u03bcg", "description": "Salmeterol/fluticasone 50/500 \u03bcg b.i.d. delivered via Accuhaler\u00ae plus tiotropium 5 \u03bcg o.d. delivered via Respimat\u00ae"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "420"}, {"groupId": "OG001", "value": "438"}, {"groupId": "OG002", "value": "425"}]}], "classes": [{"title": "Week 8", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "382"}, {"groupId": "OG001", "value": "395"}, {"groupId": "OG002", "value": "371"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.216", "spread": "0.021"}, {"groupId": "OG001", "value": "0.272", "spread": "0.021"}, {"groupId": "OG002", "value": "0.219", "spread": "0.021"}]}]}, {"title": "Week 16", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "357"}, {"groupId": "OG001", "value": "389"}, {"groupId": "OG002", "value": "371"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.221", "spread": "0.021"}, {"groupId": "OG001", "value": "0.275", "spread": "0.021"}, {"groupId": "OG002", "value": "0.217", "spread": "0.021"}]}]}, {"title": "Week 24", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "367"}, {"groupId": "OG001", "value": "385"}, {"groupId": "OG002", "value": "372"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.214", "spread": "0.022"}, {"groupId": "OG001", "value": "0.280", "spread": "0.022"}, {"groupId": "OG002", "value": "0.186", "spread": "0.022"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "Week 8", "nonInferiorityType": "SUPERIORITY", "pValue": "0.908", "pValueComment": "P-Value is two-sided", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "-0.003", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.055", "ciUpperLimit": "0.049", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.027"}, {"groupIds": ["OG001", "OG002"], "groupDescription": "Week 8", "nonInferiorityType": "SUPERIORITY", "pValue": "0.046", "pValueComment": "P-Value is two-sided", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.053", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.001", "ciUpperLimit": "0.104", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.026"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Week 16", "nonInferiorityType": "SUPERIORITY", "pValue": "0.870", "pValueComment": "P-Value is two-sided", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.004", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.047", "ciUpperLimit": "0.056", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.026"}, {"groupIds": ["OG001", "OG002"], "groupDescription": "Week 16", "nonInferiorityType": "SUPERIORITY", "pValue": "0.028", "pValueComment": "P-Value is two-sided", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.058", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.006", "ciUpperLimit": "0.109", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.026"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Week 24", "nonInferiorityType": "SUPERIORITY", "pValue": "0.303", "pValueComment": "P-Value is two-sided", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.028", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.026", "ciUpperLimit": "0.083", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.028"}, {"groupIds": ["OG001", "OG002"], "groupDescription": "Week 24", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "pValueComment": "P-Value is two-sided", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.095", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.041", "ciUpperLimit": "0.148", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.027"}]}, {"type": "SECONDARY", "title": "Change From Baseline in Forced Expiratory Flow Between 25% and 75% of Forced Vital Capacity (FEF25-75)", "description": "Forced expiratory flow during the mid (25 - 75%) portion of the FVC. It was assessed by performing spirometric assessment.", "populationDescription": "Analysis population included FAS with FEF25-75 data at the respective visit. Number analyzed signified number of participants who were evaluable for this measure at specified timepoints.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Litres/second (L/s)", "timeFrame": "Baseline, Week 8, Week 16 and Week 24", "groups": [{"id": "OG000", "title": "QVM149 150/50/80 \u03bcg", "description": "QVM149 150/50/80 \u03bcg o.d. delivered via Concept1"}, {"id": "OG001", "title": "QVM149 150/50/160 \u03bcg", "description": "QVM149 150/50/160 \u03bcg o.d. delivered via Concept1"}, {"id": "OG002", "title": "Salmeterol/Fluticasone 50/500 \u03bcg Plus Tiotropium 5 \u03bcg", "description": "Salmeterol/fluticasone 50/500 \u03bcg b.i.d. delivered via Accuhaler\u00ae plus tiotropium 5 \u03bcg o.d. delivered via Respimat\u00ae"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "420"}, {"groupId": "OG001", "value": "438"}, {"groupId": "OG002", "value": "425"}]}], "classes": [{"title": "Week 8", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "382"}, {"groupId": "OG001", "value": "395"}, {"groupId": "OG002", "value": "371"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.290", "spread": "0.027"}, {"groupId": "OG001", "value": "0.332", "spread": "0.027"}, {"groupId": "OG002", "value": "0.270", "spread": "0.027"}]}]}, {"title": "Week 16", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "357"}, {"groupId": "OG001", "value": "389"}, {"groupId": "OG002", "value": "371"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.291", "spread": "0.028"}, {"groupId": "OG001", "value": "0.355", "spread": "0.027"}, {"groupId": "OG002", "value": "0.297", "spread": "0.027"}]}]}, {"title": "Week 24", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "367"}, {"groupId": "OG001", "value": "385"}, {"groupId": "OG002", "value": "372"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.290", "spread": "0.028"}, {"groupId": "OG001", "value": "0.375", "spread": "0.028"}, {"groupId": "OG002", "value": "0.286", "spread": "0.028"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "Week 8", "nonInferiorityType": "SUPERIORITY", "pValue": "0.563", "pValueComment": "P-value is two-sided", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.020", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.048", "ciUpperLimit": "0.087", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.034"}, {"groupIds": ["OG001", "OG002"], "groupDescription": "Week 8", "nonInferiorityType": "SUPERIORITY", "pValue": "0.068", "pValueComment": "P-Value is two-sided", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.062", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.005", "ciUpperLimit": "0.129", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.034"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Week 16", "nonInferiorityType": "SUPERIORITY", "pValue": "0.844", "pValueComment": "P-Value is two-sided", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "-0.007", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.076", "ciUpperLimit": "0.062", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.035"}, {"groupIds": ["OG001", "OG002"], "groupDescription": "Week 16", "nonInferiorityType": "SUPERIORITY", "pValue": "0.097", "pValueComment": "P-Value is two-sided", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.058", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.010", "ciUpperLimit": "0.125", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.035"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Week 24", "nonInferiorityType": "SUPERIORITY", "pValue": "0.927", "pValueComment": "P-Value is two-sided", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.003", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.067", "ciUpperLimit": "0.074", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.036"}, {"groupIds": ["OG001", "OG002"], "groupDescription": "Week 24", "nonInferiorityType": "SUPERIORITY", "pValue": "0.013", "pValueComment": "P-Value is two-sided", "statisticalMethod": "MMRM", "paramType": "LS Mean", "paramValue": "0.089", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.019", "ciUpperLimit": "0.159", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.036"}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "Adverse events were collected starting on or after the time of first administration of study drug but not later than 7 days (30 days in case of a Serious Adverse Events) after the last administration, up to maximum duration of 203 days.", "description": "Any sign or symptom that occurs during the study treatment but not later than 7 days (30 days in case of a Serious Adverse Events) after the last administration.\n\nAnalysis performed on the safety set population. Safety Set consisted of all participants who received at least one dose of study medication during this study.", "eventGroups": [{"id": "EG000", "title": "QVM149 150/50/80 \u03bcg", "description": "QVM149 150/50/80 \u00b5g o.d. delivered via Concept1", "deathsNumAffected": 0, "deathsNumAtRisk": 474, "seriousNumAffected": 14, "seriousNumAtRisk": 474, "otherNumAffected": 245, "otherNumAtRisk": 474}, {"id": "EG001", "title": "QVM149 150/50/160 \u00b5g", "description": "QVM149 150/50/160 \u03bcg o.d. delivered via Concept1", "deathsNumAffected": 0, "deathsNumAtRisk": 476, "seriousNumAffected": 18, "seriousNumAtRisk": 476, "otherNumAffected": 246, "otherNumAtRisk": 476}, {"id": "EG002", "title": "Salmeterol/Fluticasone 50/500 \u03bcg Plus Tiotropium 5 \u03bcg", "description": "Salmeterol/fluticasone 50/500 \u03bcg b.i.d. delivered via Accuhaler\u00ae plus tiotropium 5 \u03bcg o.d. delivered via Respimat\u00ae", "deathsNumAffected": 1, "deathsNumAtRisk": 475, "seriousNumAffected": 19, "seriousNumAtRisk": 475, "otherNumAffected": 241, "otherNumAtRisk": 475}], "seriousEvents": [{"term": "Lymphadenopathy", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Atrioventricular block second degree", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Myocardial infarction", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Supraventricular tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Goitre", "organSystem": "Endocrine disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Abdominal hernia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Abdominal pain upper", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Colitis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Gastrointestinal haemorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Large intestine polyp", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Pancreatitis acute", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Hyperpyrexia", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Non-cardiac chest pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Cholecystitis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Cholecystitis acute", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Cholelithiasis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Atypical pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Bronchiolitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Cellulitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Diverticulitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "H1N1 influenza", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Hepatitis viral", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Lung infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Pilonidal cyst", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Postoperative abscess", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Rectal abscess", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Viral upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Contusion", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Intentional product misuse", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 475}]}, {"term": "Meniscus injury", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Wrist fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Hepatic enzyme increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Benign neoplasm", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Fibroadenoma of breast", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Large intestine benign neoplasm", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Respiratory tract neoplasm", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Carotid artery stenosis", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Guillain-Barre syndrome", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Haemorrhagic stroke", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Polyneuropathy", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Syncope", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Abortion spontaneous", "organSystem": "Pregnancy, puerperium and perinatal conditions", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Acute respiratory failure", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Asthma", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 475}]}, {"term": "Bronchiectasis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Hypoxia", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Deep vein thrombosis", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Thrombophlebitis superficial", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}], "otherEvents": [{"term": "Anaemia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Haemolysis", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Lymphadenitis", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Angina pectoris", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Atrioventricular block first degree", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Bundle branch block left", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Cardiac failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Cardiac failure chronic", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Coronary artery disease", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Palpitations", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Sinus tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 475}]}, {"term": "Supraventricular tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Deafness", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Tinnitus", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Hypothyroidism", "organSystem": "Endocrine disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Thyroid cyst", "organSystem": "Endocrine disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Blepharitis", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Cataract", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Conjunctivitis allergic", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 475}]}, {"term": "Eye disorder", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Eye pruritus", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Maculopathy", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Panophthalmitis", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Vision blurred", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Abdominal discomfort", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Abdominal distension", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Abdominal hernia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Abdominal pain", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Abdominal pain upper", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Aphthous ulcer", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Chronic gastritis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Colitis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Constipation", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Diarrhoea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 475}]}, {"term": "Dry mouth", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 475}]}, {"term": "Duodenitis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Dyspepsia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Enteritis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Gastritis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Gastrooesophageal reflux disease", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 475}]}, {"term": "Haemorrhoids", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Hiatus hernia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Hyperchlorhydria", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Inguinal hernia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Large intestine polyp", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Lip dry", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Nausea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Oesophagitis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Pancreatitis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Pancreatitis chronic", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Salivary gland calculus", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Toothache", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 7, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 475}]}, {"term": "Umbilical hernia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Vomiting", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Asthenia", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Chest discomfort", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Chest pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Chills", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Discomfort", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Fatigue", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Hyperpyrexia", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Impaired healing", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Inflammation", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Non-cardiac chest pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Oedema peripheral", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Procedural failure", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Pyrexia", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 475}]}, {"term": "Cholecystitis chronic", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Hepatic steatosis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Liver disorder", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Allergy to arthropod bite", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Atopy", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Food allergy", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Hypersensitivity", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Perennial allergy", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Abscess limb", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Acute sinusitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 475}]}, {"term": "Bacterial infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Bacterial vaginosis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Bronchitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 21, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 22, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 19, "numAtRisk": 475}]}, {"term": "Candida infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Cellulitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Chronic hepatitis C", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Conjunctivitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Cystitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Ear infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Ear infection fungal", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Erysipelas", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Eye infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Folliculitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Gastroenteritis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 475}]}, {"term": "Gingivitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Helicobacter infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Hordeolum", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Influenza", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 9, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 475}]}, {"term": "Laryngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 475}]}, {"term": "Laryngitis viral", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Localised infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Lower respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 6, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 6, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 7, "numAtRisk": 475}]}, {"term": "Nasopharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 34, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 34, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 43, "numAtRisk": 475}]}, {"term": "Oral candidiasis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 475}]}, {"term": "Oral herpes", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Oropharyngeal candidiasis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Otitis media", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Perichondritis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Pharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 18, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 17, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 10, "numAtRisk": 475}]}, {"term": "Pharyngitis bacterial", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Pharyngotonsillitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Pilonidal cyst", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 475}]}, {"term": "Post procedural infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Pulpitis dental", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 6, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 475}]}, {"term": "Respiratory tract infection viral", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 10, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 9, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 6, "numAtRisk": 475}]}, {"term": "Rhinitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 7, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 475}]}, {"term": "Sinobronchitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Sinusitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 8, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 9, "numAtRisk": 475}]}, {"term": "Skin infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Tinea versicolour", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Tonsillitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 475}]}, {"term": "Tonsillitis bacterial", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Tooth infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Tracheitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 6, "numAtRisk": 475}]}, {"term": "Tracheobronchitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 13, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 10, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 9, "numAtRisk": 475}]}, {"term": "Upper respiratory tract infection bacterial", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 9, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 9, "numAtRisk": 475}]}, {"term": "Urinary tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 6, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 475}]}, {"term": "Viral infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Viral pharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Viral rhinitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Viral tracheitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Viral upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 8, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 11, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 10, "numAtRisk": 475}]}, {"term": "Vulvovaginal candidiasis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Animal bite", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Bronchial injury", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Chest injury", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Contusion", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Epicondylitis", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Exposure to allergen", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 9, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 475}]}, {"term": "Fall", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Fibula fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Hand fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Joint dislocation", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Joint injury", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Ligament sprain", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Lip injury", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Medication error", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 475}]}, {"term": "Muscle strain", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Radius fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Rib fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Skin abrasion", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Spinal column injury", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Thermal burn", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Upper limb fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Alanine aminotransferase increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Aspartate aminotransferase increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Blood alkaline phosphatase increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Blood glucose increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Blood uric acid increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Breath sounds abnormal", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Crystal urine", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Gamma-glutamyltransferase increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Haemoglobin increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Hepatic enzyme increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Liver function test increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Red blood cells urine", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Weight decreased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Decreased appetite", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Dehydration", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Diabetes mellitus", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 475}]}, {"term": "Dyslipidaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Gout", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Hyperglycaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Hyperuricaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Hypoglycaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Mineral metabolism disorder", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Type 2 diabetes mellitus", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Arthralgia", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 475}]}, {"term": "Arthritis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Back pain", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 475}]}, {"term": "Bone pain", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Costochondritis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Fibromyalgia", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Haemarthrosis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Intervertebral disc protrusion", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Joint effusion", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Muscle spasms", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Musculoskeletal pain", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Neck pain", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Osteoarthritis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Osteochondrosis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Osteoporosis postmenopausal", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Pain in extremity", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Polyarthritis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Rotator cuff syndrome", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Spinal pain", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Synovial cyst", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Tendonitis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Infected neoplasm", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Prostatic adenoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Respiratory tract neoplasm", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Uterine leiomyoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Burning sensation", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Convulsions local", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Dizziness", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 475}]}, {"term": "Headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 10, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 15, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 9, "numAtRisk": 475}]}, {"term": "Hemianopia", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Hypersomnia", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Hypoaesthesia", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Intercostal neuralgia", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Migraine", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 475}]}, {"term": "Muscle contractions involuntary", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Neuritis", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Paraesthesia", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Phantom limb syndrome", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Polyneuropathy", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Presyncope", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Sciatica", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Syncope", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Tension headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Anxiety", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Depression", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Insomnia", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Restlessness", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Chronic kidney disease", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Leukocyturia", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Nephrolithiasis", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Nocturia", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Pyelocaliectasis", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Renal colic", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Urinary incontinence", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Breast cyst", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Breast disorder", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Breast mass", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Menorrhagia", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Menstruation irregular", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Metrorrhagia", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Prostatitis", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Allergic sinusitis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Asthma", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 125, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 114, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 125, "numAtRisk": 475}]}, {"term": "Catarrh", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Cough", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 8, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 7, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 9, "numAtRisk": 475}]}, {"term": "Dysphonia", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 8, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 7, "numAtRisk": 475}]}, {"term": "Dyspnoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 475}]}, {"term": "Epistaxis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Haemoptysis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Larynx irritation", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Nasal congestion", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Nasal obstruction", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Nasal polyps", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Nasal septum deviation", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Oropharyngeal discomfort", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Oropharyngeal pain", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 8, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 475}]}, {"term": "Pleurisy", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Productive cough", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Respiratory tract congestion", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Rhinitis allergic", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 8, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 6, "numAtRisk": 475}]}, {"term": "Rhinorrhoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Sleep apnoea syndrome", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Throat irritation", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Tonsillar hypertrophy", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Vasomotor rhinitis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Vocal cord inflammation", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Alopecia", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Dermatitis allergic", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Dermatitis atopic", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Dermatitis contact", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Dry skin", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Eczema", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Pruritus", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Psoriasis", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Skin burning sensation", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Urticaria", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Tooth extraction", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Hot flush", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Hypertension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 7, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 475}]}, {"term": "Malignant hypertension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Peripheral venous disease", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Phlebitis", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 475}]}, {"term": "Varicophlebitis", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}, {"term": "Varicose vein", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (22.0)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 474}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 476}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 475}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial."}, "pointOfContact": {"title": "Study Director", "organization": "Novartis Pharmaceuticals", "email": "Novartis.email@novartis.com", "phone": "862-778-8300"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot", "hasProtocol": true, "hasSap": false, "hasIcf": false, "label": "Study Protocol", "date": "2017-11-16", "uploadDate": "2020-07-15T12:04", "filename": "Prot_000.pdf", "size": 21441456}, {"typeAbbrev": "SAP", "hasProtocol": false, "hasSap": true, "hasIcf": false, "label": "Statistical Analysis Plan", "date": "2019-09-17", "uploadDate": "2020-07-15T12:04", "filename": "SAP_001.pdf", "size": 1211615}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24", "removedCountries": ["Singapore"]}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000068298", "term": "Fluticasone"}, {"id": "D000069447", "term": "Tiotropium Bromide"}, {"id": "D000068299", "term": "Salmeterol Xinafoate"}], "ancestors": [{"id": "D000000893", "term": "Anti-Inflammatory Agents"}, {"id": "D000001993", "term": "Bronchodilator Agents"}, {"id": "D000001337", "term": "Autonomic Agents"}, {"id": "D000018373", "term": "Peripheral Nervous System Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000018927", "term": "Anti-Asthmatic Agents"}, {"id": "D000019141", "term": "Respiratory System Agents"}, {"id": "D000003879", "term": "Dermatologic Agents"}, {"id": "D000018926", "term": "Anti-Allergic Agents"}, {"id": "D000010276", "term": "Parasympatholytics"}, {"id": "D000018680", "term": "Cholinergic Antagonists"}, {"id": "D000018678", "term": "Cholinergic Agents"}, {"id": "D000018377", "term": "Neurotransmitter Agents"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}, {"id": "D000058666", "term": "Adrenergic beta-2 Receptor Agonists"}, {"id": "D000000318", "term": "Adrenergic beta-Agonists"}, {"id": "D000000322", "term": "Adrenergic Agonists"}, {"id": "D000018663", "term": "Adrenergic Agents"}], "browseLeaves": [{"id": "M290", "name": "Mometasone Furoate", "relevance": "LOW"}, {"id": "M5241", "name": "Bromides", "relevance": "LOW"}, {"id": "M250", "name": "Fluticasone", "asFound": "Pembrolizumab", "relevance": "HIGH"}, {"id": "M353494", "name": "Xhance", "relevance": "LOW"}, {"id": "M416", "name": "Tiotropium Bromide", "asFound": "Melanoma", "relevance": "HIGH"}, {"id": "M251", "name": "Salmeterol Xinafoate", "asFound": "Metabolism", "relevance": "HIGH"}, {"id": "M4217", "name": "Anti-Inflammatory Agents", "relevance": "LOW"}, {"id": "M5269", "name": "Bronchodilator Agents", "relevance": "LOW"}, {"id": "M20963", "name": "Anti-Asthmatic Agents", "relevance": "LOW"}, {"id": "M21137", "name": "Respiratory System Agents", "relevance": "LOW"}, {"id": "M7074", "name": "Dermatologic Agents", "relevance": "LOW"}, {"id": "M20962", "name": "Anti-Allergic Agents", "relevance": "LOW"}, {"id": "M13189", "name": "Parasympatholytics", "relevance": "LOW"}, {"id": "M20760", "name": "Cholinergic Antagonists", "relevance": "LOW"}, {"id": "M20758", "name": "Cholinergic Agents", "relevance": "LOW"}, {"id": "M20504", "name": "Neurotransmitter Agents", "relevance": "LOW"}, {"id": "M20746", "name": "Adrenergic Agents", "relevance": "LOW"}, {"id": "M3670", "name": "Adrenergic beta-Agonists", "relevance": "LOW"}, {"id": "M3673", "name": "Adrenergic Agonists", "relevance": "LOW"}], "browseBranches": [{"abbrev": "AAll", "name": "Anti-Allergic Agents"}, {"abbrev": "Infl", "name": "Anti-Inflammatory Agents"}, {"abbrev": "Derm", "name": "Dermatologic Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "AntiConv", "name": "Anticonvulsants"}, {"abbrev": "Resp", "name": "Respiratory System Agents"}]}}, "hasResults": true}